TELA Bio, Inc. cotiza a 1.10 USD y tiene una capitalización bursátil de $49M. En los últimos 12 meses ha facturado $80M con un margen de flujo de caja libre del -35.7%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for he…
| Periodo | 2026-11 | 2026-08 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | — | $-0.20 | $-0.17 | $-0.19 |
| Estimado | $-0.15 | $-0.18 | $-0.18 | $-0.20 |
| Sorpresa | — | -11.1% | +5.6% | +5.0% |
| Métrica | TELA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 67.7% | 57.0% | +10.6% |
| Operating Margin | -42.0% | -38.6% | -3.4% |
| Net Margin | -48.4% | -33.6% | -14.8% |
| FCF Margin | -35.7% | -13.9% | -21.9% |
| ROE | -615.1% | -40.4% | -574.7% |
| ROA | -47.7% | -32.0% | -15.7% |
| Current Ratio | 4.20 | 2.84 | +1.36 |
| Debt / Equity | 8.82 | 0.28 | +8.54 |